Adverse cutaneous reactions to drugs

Clinical Medicine

Volumn 2, Issue 1, 2002, Pages 15-19

  Breathnach, Stephen M ^a,b  

^a ST THOMAS HOSPITAL   (United Kingdom)

^b EPSOM AND ST HELIER UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

CPD; Drug eruptions

Indexed keywords

ADRENALIN; ALBUMIN; AMINOPHYLLINE; AMOXICILLIN; AMPICILLIN; ANESTHETIC AGENT; ANTICONVULSIVE AGENT; ANTIHISTAMINIC AGENT; ANTIINFECTIVE AGENT; CHLORPHENIRAMINE MALEATE; CONTRAST MEDIUM; CORTICOSTEROID; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DIURETIC AGENT; FUROSEMIDE; HYDROCHLOROTHIAZIDE; HYDROCORTISONE SODIUM PHOSPHATE; HYPNOTIC SEDATIVE AGENT; IMMUNOSUPPRESSIVE AGENT; MUSCLE RELAXANT AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PENICILLIN DERIVATIVE; PREDNISOLONE; SALBUTAMOL; TERBUTALINE; TRANQUILIZER; UNINDEXED DRUG; VACCINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANAPHYLAXIS; ANGIONEUROTIC EDEMA; DRUG ERUPTION; DRUG HYPERSENSITIVITY; DRUG SENSITIVITY; ERYTHEMA MULTIFORME; ERYTHRODERMA; EXFOLIATIVE DERMATITIS; HUMAN; PHOTOSENSITIVITY DISORDER; PROVOCATION TEST; RASH; REVIEW; SERUM SICKNESS; SKIN BIOPSY; SKIN MANIFESTATION; SKIN TEST; STEVENS JOHNSON SYNDROME; TOXIC EPIDERMAL NECROLYSIS; URTICARIA; VASCULITIS;

EID: 0036181431     PISSN: 14702118     EISSN: None     Source Type: Journal    
DOI: 10.7861/clinmedicine.2-1-15     Document Type: Review

References (14)

1. Saiag P, Caumes E, Chosidow O, Revuz J, Roujeau JC. Drug-induced toxic epidermal necrolysis (Lyell syndrome) in patients infected with the human immunodeficiency virus. J Am Acad Dermatol 1992;26:567-74.
2. Chan HL, Stern RS, Arndt KA, Langlois J, et al. The incidence of erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis. A population-based study with particular reference to reactions caused by drugs among outpatients. Arch Dermatol 1990;126:43-7.
3. Chosidow O, Bourgault L, Roujeau JC. Drug rashes. What are the targets of cell-mediated cytotoxicity? Arch Dermatol 1994;130:627-9.
4. Breathnach SM. Drug reactions. In: Champion RH, Burton JL, Burns DA, Breathnach SM (eds). Textbook of dermatology, 6th edn. Oxford: Blackwell Science, 1998:3349-518.
5. Litt JZ. Drug eruption reference manual 2001. New York: Parthenon Publishing, 2001.
6. Sontheimer RD, Houpt KR. DIDMOHS: a proposed consensus nomenclature for the drug-induced delayed multiorgan hypersensitivity syndrome. Arch Dermatol 1998; 134:874-6.
7. Roujeau JC, Stern RS. Severe adverse cutaneous reactions to drugs. Review. N Engl J Med 1994;331:1272-85.
8. Gadde J, Spence M, Wheeler B, Adkinson NF Jr. Clinical experience with penicillin skin testing in a large inner-city STD clinic. JAMA 1993;270:2456-63.
9. Barbaud A, Reichert-Penetrat S, Tréchot P, Jacquin-Petit MA, et al. The use of skin testing in the investigation of cutaneous adverse drug reactions. Br J Dermatol 1998;139:49-58.
10. Merk HF, Baron J, Kawakubo Y, Hertl M, Jugert F. Review. Metabolites and allergic drug reactions. Review. Clin Exp Allergy 1998;28(Suppl 4):21-4.
11. Chopra S, Levell NJ, Cowley G, Gilkes JJ. Systemic corticosteroids in the phenytoin hypersensitivity syndrome. Review. Br J Dermatol 1996;134:1109-12.
12. Roujeau JC, Revuz J. Intensive care in dermatology. In: Champion RH, Pye RJ (eds). Recent advances in dermatology. Edinburgh: Churchill Livingstone, 1990;8:85-99.
13. Roujeau JC. Treatment of severe drug eruptions. Review. J Dermatol 1999;26:718-22.
14. Breathnach SM, Hintner H. Adverse drug reactions and the skin. Oxford: Blackwell Science Ltd, 1992.